| Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy SK Rehman, J Haynes, E Collignon, KR Brown, Y Wang, AML Nixon, ... Cell 184 (1), 226-242. e21, 2021 | 290 | 2021 |
| Proteogenomic characterization of pancreatic ductal adenocarcinoma L Cao, C Huang, DC Zhou, Y Hu, TM Lih, SR Savage, K Krug, DJ Clark, ... Cell 184 (19), 5031-5052. e26, 2021 | 270 | 2021 |
| Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer R Shi, N Radulovich, C Ng, N Liu, H Notsuda, M Cabanero, ... Clinical Cancer Research 26 (5), 1162-1174, 2020 | 190 | 2020 |
| Software for the Integration of Multiomics Experiments in Bioconductor M Ramos, L Schiffer, A Re, R Azhar, A Basunia, C Rodriguez, T Chan, ... Cancer research 77 (21), e39-e42, 2017 | 100 | 2017 |
| Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer KL Thu, J Silvester, MJ Elliott, W Ba-Alawi, MH Duncan, AC Elia, AS Mer, ... Proceedings of the National Academy of Sciences 115 (7), E1570-E1577, 2018 | 69 | 2018 |
| Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling M Wang, J Lindberg, D Klevebring, C Nilsson, AS Mer, M Rantalainen, ... Leukemia 31 (10), 2029-2036, 2017 | 67 | 2017 |
| Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer CA Chang, J Jen, S Jiang, A Sayad, AS Mer, KR Brown, AML Nixon, ... Cancer discovery 12 (4), 1022-1045, 2022 | 58 | 2022 |
| Expression levels of long non-coding RNAs are prognostic for AML outcome AS Mer, J Lindberg, C Nilsson, D Klevebring, M Wang, H Grönberg, ... Journal of hematology & oncology 11 (1), 1-13, 2018 | 54 | 2018 |
| Integrative pharmacogenomics analysis of patient-derived xenografts AS Mer, W Ba-Alawi, P Smirnov, YX Wang, B Brew, J Ortmann, MS Tsao, ... Cancer research 79 (17), 4539-4550, 2019 | 41 | 2019 |
| Biological and therapeutic implications of a unique subtype of NPM1 mutated AML AS Mer, EM Heath, SA Madani Tonekaboni, N Dogan-Artun, SK Nair, ... Nature communications 12 (1), 1-13, 2021 | 34 | 2021 |
| Drug sensitivity prediction from cell line-based pharmacogenomics data: guidelines for developing machine learning models H Sharifi-Noghabi, S Jahangiri-Tazehkand, P Smirnov, C Hon, ... Briefings in Bioinformatics 22 (6), bbab294, 2021 | 30 | 2021 |
| CellWhere: graphical display of interaction networks organized on subcellular localizations L Zhu, A Malatras, M Thorley, I Aghoghogbe, A Mer, S Duguez, ... Nucleic acids research 43 (W1), W571-W575, 2015 | 22 | 2015 |
| MicroRNAs modulate the dynamics of the NF-κB signaling pathway C Vaz, AS Mer, A Bhattacharya, R Ramaswamy PLoS One 6 (11), e27774, 2011 | 19 | 2011 |
| A novel approach for protein subcellular location prediction using amino acid exposure AS Mer, MA Andrade-Navarro BMC bioinformatics 14 (1), 1-13, 2013 | 17 | 2013 |
| PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis N Feizi, SK Nair, P Smirnov, G Beri, C Eeles, PN Esfahani, M Nakano, ... Nucleic acids research 50 (D1), D1348-D1357, 2022 | 15 | 2022 |
| Orchestrating and sharing large multimodal data for transparent and reproducible research A Mammoliti, P Smirnov, M Nakano, Z Safikhani, C Eeles, H Seo, SK Nair, ... Nature Communications 12 (1), 1-10, 2021 | 15 | 2021 |
| IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells B Nachmias, DH Khan, V Voisin, AS Mer, GE Thomas, N Segev, ... Leukemia 36 (5), 1283-1295, 2022 | 12 | 2022 |
| Assessing therapy response in patient-derived xenografts J Ortmann, L Rampášek, E Tai, AS Mer, R Shi, EL Stewart, C Mascaux, ... Science translational medicine 13 (620), eabf4969, 2021 | 5 | 2021 |
| Highlights from the 16th International Society for Computational Biology Student Council Symposium 2020 WL Cuypers, HM Dönertaş, JK Grewal, N Fatima, C Donnelly, AS Mer, ... F1000Research 10, 2021 | 5 | 2021 |
| Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing N El-Hachem, W Ba-alawi, I Smith, AS Mer, B Haibe-Kains Pharmacogenomics 18 (16), 1469-1472, 2017 | 5 | 2017 |
Benjamin Haibe-KainsScientist (Principal Investigator), Princess Margaret Cancer Centre, University Health NetworkVerified email at uhnresearch.ca
